Redefining biomarkers in heart failure

Heart failure (HF) is the end result of many different cardiac and non-cardiac abnormalities leading to a complex clinical entity. In this view, the use of biomarkers in HF should be deeply reconsidered; indeed, the same biomarker may carry a different significance in patients with preserved or redu...

Full description

Saved in:
Bibliographic Details
Published in:Heart failure reviews 2018-03, Vol.23 (2), p.237-253
Main Authors: Correale, Michele, Monaco, Ilenia, Brunetti, Natale Daniele, Di Biase, Matteo, Metra, Marco, Nodari, Savina, Butler, Javed, Gheorghiade, Mihi
Format: Article
Language:English
Subjects:
Biomarkers
Biomarkers - blood
Cardiology
Heart diseases
Heart failure
Heart Failure - blood
Heart Failure - physiopathology
Humans
Medicine
Medicine & Public Health
Stroke Volume - physiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Heart failure (HF) is the end result of many different cardiac and non-cardiac abnormalities leading to a complex clinical entity. In this view, the use of biomarkers in HF should be deeply reconsidered; indeed, the same biomarker may carry a different significance in patients with preserved or reduced EF. The aim of this review is to reconsider the role of biomarkers in HF, based on the different clinical characteristics of this syndrome. The role of cardiac and non-cardiac biomarkers will be reviewed with respect of the different clinical manifestations of this syndrome.
ISSN:1382-4147
1573-7322
DOI:10.1007/s10741-018-9683-2